Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Frontiers in Immunology|September 27, 2021
Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 MortalityFederica Defendi, Corentin Leroy, Olivier Epaulard, et al.Cytometry. Part B, Clinical Cytometry|November 4, 2014
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter studyChantal Fossat, Mikael Roussel, Isabelle Arnoux, et al.Frontiers in Immunology|August 1, 2022
Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe OutcomeGiovanna Clavarino, Corentin Leroy, Olivier Epaulard, et al.BMJ Open|August 22, 2025
Flow cytometric lyophilised reagent tube assay for peripheral blood neutrophil myeloperoxidase expression to rule out myelodysplastic neoplasms at a university hospital: a diagnostic accuracy studyCharlotte Planta, Laura Scheffen, Marie-Christine Jacob, et al.Haematologica|August 6, 2002
Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemiaMarc Maynadié, Luc Gerland, Serge Aho, et al.Journal of Leukocyte Biology|August 6, 2005
Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine productionNathalie Bendriss-Vermare, Stéphanie Burg, Holger Kanzler, et al.The Journal of Pathology. Clinical Research|August 10, 2021
c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphomaAntonin Bouroumeau, Lucile Bussot, Thierry Bonnefoix, et al.British Journal of Haematology|April 25, 2009
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemiaFrancine Garnache-Ottou, Jean Feuillard, Christophe Ferrand, et al.Cytometry. Part B, Clinical Cytometry|August 18, 2020
Multicentric MFI30 study: Standardization of flow cytometry analysis of CD30 expression in non-Hodgkin lymphomaAgathe Debliquis, Lucile Baseggio, Sabrina Bouyer, et al.Blood|February 28, 2002
Clinical and biologic features of CD4(+)CD56(+) malignanciesJean Feuillard, Marie-Christine Jacob, Françoise Valensi, et al.Pageof 5